By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Imprimis Pharmaceuticals 

437 South Highway 101
Suite 209
Solana Beach  California    U.S.A.
Phone: 858-433-2800 Fax: n/a



Company News
Imprimis (immy) Announces Third Quarter 2015 Financial Results And Provides Business Update 11/12/2015 4:32:25 PM
Imprimis (immy)' Ophthalmic Formulations To Be Presented At The 2015 American Academy of Ophthalmology Meeting 11/12/2015 10:44:45 AM
Imprimis (immy) Announces Plans To Register Its Texas Pharmacy With The FDA As An Outsourcing Facility 10/29/2015 10:08:15 AM
Imprimis (immy) Announces New Economic Study Demonstrating $8.7 Billion In Potential Cost Savings Over The Next 10 Years With The Adoption Of Dropless Therapy 10/26/2015 12:04:36 PM
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug 10/22/2015 10:48:02 AM
Imprimis Pharmaceuticals (immy) Announces Preliminary Revenue For Third Quarter 2015 10/20/2015 11:24:00 AM
Imprimis Pharmaceuticals (immy) Closes The Acquisition Of The Assets Of The Largest Provider Of Compounded Sinus Medications In The U.S. 10/20/2015 8:32:20 AM
Imprimis Pharmaceuticals (immy) To Present At 6th Annual Craig-Hallum Alpha Select Conference 9/10/2015 6:40:29 AM
Imprimis Pharmaceuticals (immy) Appoints Anthony J. Principi To Its Board Of Directors 9/2/2015 6:44:04 AM
Imprimis Pharmaceuticals (immy) Announces Second Quarter 2015 Financial Results And Provides Business Update 8/13/2015 7:03:52 AM